A Study to Evaluate the Safety and Efficacy of Zanubrutinib in Participants With Primary Membranous Nephropathy

Condition:   Primary Membranous Nephropathy Interventions:   Drug: Zanubrutinib;   Drug: Tacrolimus Sponsor:   BeiGene Not yet recruiting

Source: ClinicalTrials.gov - January 31, 2023 Category: Research Source Type: clinical trials